Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Signal Transduct Target Ther. 2023 Mar 22;8(1):119. doi: 10.1038/s41392-023-01324-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glioblastoma* / drug therapy
  • Glioblastoma* / genetics
  • Humans
  • Poly(ADP-ribose) Polymerase Inhibitors / pharmacology
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use
  • Ribose / therapeutic use
  • Triterpenes*

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • stellettin B
  • Ribose
  • Triterpenes